Learn the latest on Illumina's acquisition of GRAIL and what each regulatory milestone and development means for the future of preventing, detecting, and treating cancer.


  • September 5, 2023

How a federal agency’s blocking of a company merger threatens cancer care for veterans

The San Diego Union-Tribune

  • June 29, 2023

The FTC’s double standard is threatening America’s health, innovation, and patients

Washington Examiner

  • June 13, 2023

GOP Lawmakers, AGs Back Illumina Against FTC At 5th Circ.


  • June 7, 2023

Biden’s FTC is blocking a game-changer for cancer patients

The Hill

  • June 6, 2023

Merger cops’ sandcastle arguments risk crumbling

Reuters Breakingviews

  • April 28, 2023

Lina Khan Blocks Cancer Cures

The Wall Street Journal

  • April 15, 2023

FTC rules in its own favor and against cancer patients

Washington Times

  • April 4, 2023

A big test for Biden’s antitrust cops | The FTC is wrong about Illumina

Semafor Business

  • April 4, 2023

Illumina battle with regulators threatens cancer breakthrough, warn Grail alumni

Financial Times

  • April 3, 2023

The FTC’s Unholy Antitrust Grail

The Wall Street Journal

  • February 23, 2023

The FTC’s Antitrust Collusion

The Wall Street Journal

  • November 23, 2022

Private Sector is Key to Landing Biden’s Cancer Moonshot

Boston Business Journal

  • March 21, 2022

Could Biden’s FTC trip up his cancer moonshot?

POLITICO’s West Wing Playbook

  • January 28, 2022

Biden Renews Pushback Against Stock Buybacks

New York Times DealBook

  • January 26, 2022

Illumina Will Seek to Overcome EU Antitrust Concerns Over Grail Deal, CEO Says


  • January 16, 2022

Illumina Says EU Probe of $8BN Grail Deal Could Hit Biotech Investment

Financial Times

  • December 8, 2021

Regulatory Hurdles Block a Cancer Miracle


  • August 18, 2021

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

Press Release

  • March 30, 2021

Illumina Committed to Pursuing GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test

Press Release

  • September 20, 2020

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Press Release

Displaying 20 of 20 News Articles